Related Experiment Video
Updated: May 28, 2026

RhoC GTPase Activation Assay
Published on: August 22, 2010
Does Ras/Rho Have Skin in the Game: The Importance of the Isoprenoid Biosynthesis Pathway in Merkel Cell Carcinoma
Louise N Blaha1,2, Nicole M Derosia1,2, Jeffrey D Neighbors1,2
1Penn State Cancer Institute, Hershey, PA 17033, USA.
Background:
Merkel cell carcinoma (MCC) is a rare malignancy of the skin caused by Merkel cell polyomavirus (80% of cases) or by ultraviolet (UV) sun exposure (20% of cases). The isoprenoid biosynthesis pathway (IBP) is an essential metabolic pathway shown to be upregulated in tumorigenesis, causing aberrant activation of Ras and Rho GTPases and resulting in unregulated cellular proliferation and survival.
Methods:
Through the use of pharmacological inhibitors of the IBP, we assessed the role of the IBP and its downstream targets in viral-positive and viral-negative MCC cell lines. To identify the most critical IBP intermediates, cellular metabolic activity, cell death and cell cycle distribution were measured after IBP perturbation.
Results:
Across all cell lines, treatment with IBP inhibitors, especially fluvastatin, decreased metabolic activity; however, perturbation of different intermediates resulted in variable responses between viral-positive and viral-negative cell lines.
Conclusions:
Our findings demonstrate varying dependence on the IBP between viral-positive and viral-negative MCC and highlight the importance of cellular dynamics when determining a treatment regimen for patients with MCC.
Insights
Merkel cell carcinoma (MCC) treatment depends on viral status. Inhibiting the isoprenoid biosynthesis pathway (IBP) affects cancer cells differently, showing varied dependence on this metabolic pathway in viral-positive versus viral-negative MCC.
Area of Science:
- Oncology
- Metabolic pathways
- Cancer biology
Background:
- Merkel cell carcinoma (MCC) is a rare skin cancer linked to Merkel cell polyomavirus or UV exposure.
- The isoprenoid biosynthesis pathway (IBP) is crucial for cell proliferation and survival, often upregulated in cancers.
- Aberrant IBP activation contributes to uncontrolled cell growth via Ras and Rho GTPases.
Purpose of the Study:
- To investigate the role of the IBP in viral-positive and viral-negative MCC.
- To assess the impact of IBP pharmacological inhibitors on MCC cell lines.
- To identify critical IBP intermediates influencing cancer cell behavior.
Main Methods:
- Utilized pharmacological inhibitors targeting the IBP in MCC cell lines.
- Assessed cellular metabolic activity, cell death, and cell cycle distribution.
- Perturbed specific IBP intermediates to observe differential responses.
Main Results:
- IBP inhibitors, notably fluvastatin, reduced metabolic activity across all tested MCC cell lines.
- Responses to IBP perturbation varied significantly between viral-positive and viral-negative MCC cell lines.
- Specific IBP intermediates showed differential importance depending on viral status.
Conclusions:
- Demonstrated distinct dependencies on the IBP between viral-positive and viral-negative MCC.
- Highlighted the critical role of cellular dynamics in MCC treatment strategies.
- Emphasized the need for personalized treatment regimens based on MCC subtype.
Related Concept Videos
Small GTPases - Ras and Rho
Three regulatory proteins control their activity:
The Ras Gene
Ras is a superfamily...
The Ras Gene
Ras is a superfamily...
MAPK Signaling Cascades
Cell Polarization by Rho Proteins
Abnormal Proliferation
